In a cancer cachexia animal model, genetic ablation of TLR4 elicited a less severe cachexia with an accompanying lower body weight loss, greater lean body and fat mass, and clinical evidence of reduced wasting compared with the age and weight-matched WT mice11. Here, TLR4 is linked to cancer.